Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
2
×
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
alder biopharmaceutical
american academy of neurology
amgen
atogepant
biohaven
biotech
bob azelby
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
bristol-myers squibb
calcitonin gene-related peptide
clinical data
detroit blog main
detroit top stories
drugs
eli lilly
eptinezumab
erenumab
fda
fremanezumab
galcanezumab
genfit
gilead sciences
impel neuropharma
indiana blog main
What
drug
2
×
new
2
×
approval
approved
arguments
big
class
commercialized
companies
competitors
data
decades
disease
drugs
fatty
fda
horizon
intercept
known
liver
make
marketed
medicine
meeting
migraine
nash
neuro
nonalcoholic
oral
potential
steatohepatitis
therapies
track
won
year
Language
Current search:
allergan
×
drug
×
new
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
